Why Hims & Hers Stock Tumbled on Tuesday
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock.
Hims & Hers Health (NYSE: HIMS) stock slid 7.4% through 11:10 a.m. ET Tuesday after Bank of America raised its price target on the pharmaceuticals stock in the worst way possible.
BofA added only $1 to its Hims & Hers price target, making it $22 a share.
Which is actually $10 less than Hims & Hers stock is worth today.
